A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2-Reference-Cited by-同舟云学术

A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2

Published:2021 Issue:33 Volume:11 Page:20006-20035
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Damodharan Kannan¹²³⁴⁵^ORCID,Arumugam Gandarvakottai Senthilkumar⁵⁶⁷³⁴,Ganesan Suresh⁵⁶⁷³⁴,Doble Mukesh⁵⁶⁷³⁴^ORCID,Thennarasu Sathiah¹²³⁴

Affiliation:

1. Department of Organic and Bioorganic Chemistry

2. CSIR-Central Leather Research Institute (CLRI)

3. Chennai

4. India

5. Bioengineering and Drug Design Lab

6. Department of Biotechnology

7. Indian Institute of Technology Madras (IITM)

Abstract

We describe updated information on the various vaccines available over the last two decades, along with recent progress in developing 63 diverse vaccines against SARS-CoV-2.

Funder

Science and Engineering Research Board

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/RA/D0RA09668G

Reference199 articles.

1. Peptide-Based Vaccines: Current Progress and Future Challenges

2. Current Status of COVID‐19 (Pre)Clinical Vaccine Development

3. The contribution of vaccination to global health: past, present and future